What is Quest Diagnostics's expected EPS for Q3 2026?

Analysts expect Quest Diagnostics (DGX) to report consensus EPS of approximately $2.85 for Q3 2026. Estimates range from $2.74 to $2.91.

What revenue do analysts expect for Quest Diagnostics in Q3 2026?

The consensus revenue forecast for Quest Diagnostics (DGX) in Q3 2026 is approximately $3.05B. Forecasts range from $2.96B to $3.09B.

How many analysts cover Quest Diagnostics?

10 analysts contribute to the Quest Diagnostics (DGX) Q3 2026 consensus estimate.

Has Quest Diagnostics beaten earnings estimates recently?

Quest Diagnostics beat analyst EPS estimates in 2 of the last 2 quarters. Quest Diagnostics beat revenue estimates in 2 of 2. In the most recent quarter (Q2 2026), Quest Diagnostics EPS beat by 10.5% and revenue beat by 2.4%.

When does Quest Diagnostics report Q3 2026 earnings?

Quest Diagnostics (DGX) is expected to report Q3 2026 earnings on October 20, 2026 before market open.

DGX Q3 2026 earnings estimate

Consensus EPS · Q3 2026

$2.85

Consensus revenue · Q3 2026

$3B

Analysts

Expected report

Oct 20, 2026

Before open

Upcoming earnings

Locks in 84 days 16 hours · BMO: Locks 8:00 PM ET previous day

Revenue$3B$3B – $3.1B

EPS$2.85$2.74 – $2.91

What to watch

Analyst ratings: Mixed

Make your prediction

Analyst consensus

Based on estimates from 10 analysts.

Metric	Low	Consensus	High
Revenue	$3B	$3B	$3.1B
EPS	$2.74	$2.85	$2.91
EBITDA	$629.1M	$639.7M	$656.6M
EBIT	$491.3M	$499.6M	$512.8M
Net income	$309.5M	$319.7M	$329.9M

Revenue$3B
EPS$2.85
EBITDA$639.7M
EBIT$499.6M
Net income$319.7M

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q2 2026	$3B	$3B	+2.4%	$3.12	$2.82	+10.5%
Q1 2026	$2.9B	$2.8B	+2.3%	$2.50	$2.37	+5.7%

Q2 2026+2.4%+10.5%
Q1 2026+2.3%+5.7%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Quest Diagnostics (DGX) Q3 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 5 analysts.

Low: $220.00
Consensus: $237.43
Median: $235.00
High: $255.00
Current: $227.86
Upside: +4.2%

Upside calculated vs most recent trading price of $227.86.

Analyst ratings

Consensus: Hold — based on 34 analyst ratings.

Buy 13Hold 18Sell 3

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Jul 24, 2026	UBS	maintain	Neutral	Neutral
Jul 24, 2026	Truist Securities	maintain	Hold	Hold
Jul 24, 2026	Mizuho	maintain	Outperform	Outperform
Jul 24, 2026	Barclays	maintain	Overweight	Overweight
Jul 24, 2026	Baird	maintain	Neutral	Neutral
Jul 13, 2026	Baird	maintain	Neutral	Neutral
Apr 22, 2026	UBS	maintain	Neutral	Neutral
Apr 22, 2026	Truist Securities	maintain	Hold	Hold
Apr 22, 2026	Barclays	maintain	Overweight	Overweight
Apr 22, 2026	Baird	maintain	Neutral	Neutral

Jul 24, 2026UBSNeutral
Jul 24, 2026Truist SecuritiesHold
Jul 24, 2026MizuhoOutperform
Jul 24, 2026BarclaysOverweight
Jul 24, 2026BairdNeutral
Jul 13, 2026BairdNeutral
Apr 22, 2026UBSNeutral
Apr 22, 2026Truist SecuritiesHold
Apr 22, 2026BarclaysOverweight
Apr 22, 2026BairdNeutral

Frequently asked questions

Quest Diagnostics (DGX) Key Financials

Charts, filings, and peer comparison for every metric

Trains Forecasting

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

DGX Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation